Reflections on the Innovative Medicines Initiative

被引：0
|
作者：
Michel Goldman
机构：
[1] Michel Goldman is Executive Director of the Innovative Medicines Initiative,
[2] B-1060 Brussels,undefined
[3] Belgium.,undefined
来源：
Nature Reviews Drug Discovery | 2011年 / 10卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The pharmaceutical industry is developing new collaborative models for drug development. This article discusses the experience so far of the Innovative Medicines Initiative, which is currently the largest public–private partnership that is dedicated to pharmaceutical innovation, highlighting lessons learned for the success of precompetitive consortia.
引用
收藏
页码：321 / 322
页数：1
相关论文
共 50 条
  • [11] Impact of the Innovative Medicines Initiative on vaccine development
    Philippe Denoel
    Patricia Londoño-Hayes
    Magda Chlebus
    Magdalena Rodriguez de Azero
    Nature Reviews Drug Discovery, 2018, 17 : 769 - 770
  • [12] The European Innovative Medicines Initiative: Progress to Date
    Faure J.-E.
    Dyląg T.
    Norstedt I.
    Matthiessen L.
    Pharmaceutical Medicine, 2018, 32 (4) : 243 - 249
  • [13] Impact of the Innovative Medicines Initiative on vaccine development
    Denoel, Philippe
    Londono-Hayes, Patricia
    Chlebus, Magda
    de Azero, Magdalena Rodriguez
    NATURE REVIEWS DRUG DISCOVERY, 2018, 17 (11) : 769 - 770
  • [14] The Innovative Medicines Initiative: an engine for regulatory science
    Goldman, Michel
    Seigneuret, Nathalie
    Eichler, Hans-Georg
    NATURE REVIEWS DRUG DISCOVERY, 2015, 14 (01) : 1 - 2
  • [15] First Innovative Medicines Initiative Ebola projects launched
    EUROSURVEILLANCE, 2015, 20 (03): : 13 - 13
  • [16] Innovative Medicines Initiative Largest bioscience PPP failing
    Adriaanse, Chris
    CHEMISTRY & INDUSTRY, 2010, (18) : 6 - 6
  • [17] The Innovative Medicines Initiative: A European Response to the Innovation Challenge
    Goldman, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 (03) : 418 - 425
  • [18] The Innovative Medicines Initiative moves translational immunology forward
    Goldman, Michel
    Wittelsberger, Angela
    De Magistris, Maria-Teresa
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2013, 43 (02) : 298 - 302
  • [19] Scientific Advances in Diabetes: The Impact of the Innovative Medicines Initiative
    Brito, Maria de Fatima
    Torre, Carla
    Silva-Lima, Beatriz
    FRONTIERS IN MEDICINE, 2021, 8
  • [20] Biomarkers for disease modification trials - The innovative medicines initiative and AddNeuroMed
    Lovestone, S.
    Francis, P.
    Strandgaard, K.
    JOURNAL OF NUTRITION HEALTH & AGING, 2007, 11 (04): : 359 - 361
12345